Lipoprotein (a)(Lp (a)) is a low-density lipoprotein (LDL) cholesterol-like particle bound to
apolipoprotein (a). Increased Lp (a) levels are an independent, heritable causal risk factor …

Abundant evidence links elevated levels of lipoprotein (a)(Lp (a)) to higher cardiovascular
risk, leaving clinicians with the challenge of what measures to take to mitigate Lp (a) …

Moreover, over the last few years the approach to treatment of patients with a high
cardiovascular risk has totally changed from treatment aimed at a specific risk factor (ie …

Background and aims Elevated lipoprotein (a)[Lp (a)] is an independent risk factor for
cardiovascular disease. In clinical practice, Lp (a) is mostly measured only once assuming …

Statin intolerance is a clinical syndrome whereby adverse effects (AEs) associated with
statin therapy [most commonly statin‐associated muscle symptoms (SAMS)] result in the …

Since the 2019 National Lipid Association (NLA) Scientific Statement on Use of Lipoprotein
(a) in Clinical Practice was issued, accumulating epidemiological data have clarified the …

Abstract Purpose of Review Over the past decades, genetic and observational evidence has
positioned lipoprotein (a) as novel important and independent risk factor for cardiovascular …

Randomized controlled trials (RCTs) show that decreases in low-density lipoprotein
cholesterol (LDL-C) by the use of statins cause a significant reduction in the development of …

Lipoprotein (a)[Lp (a)] is a well-established risk factor for cardiovascular disease,
predisposing to major cardiovascular events, including coronary heart disease, stroke, aortic …

Abstract Lipoprotein (a), or Lp (a), is structurally like low‐density lipoprotein (LDL) but differs
in that it contains glycoprotein apolipoprotein (a)[apo (a)]. Due to its prothrombotic and …